Filing Details
Armata Pharmaceuticals, Inc. (AMEX:ARMP) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event.
8k filedAMEX:ARMP
Armata Pharmaceuticals, Inc. (ARMP) Reports Material Event to SEC
Filing Details Armata Pharmaceuticals, Inc. (AMEX:ARMP) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event. Market Context…
Market Context
Armata Pharmaceuticals, Inc.'s stock currently trades at $3.97 with a market capitalization of $391.7M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Armata Pharmaceuticals, Inc.'s stock.
All SEC filings for Armata Pharmaceuticals, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ARMP Stock Page
Frequently Asked Questions
Where can I read ARMP's SEC filings?
Browse all filings on our ARMP SEC filings page.
What types of SEC filings does Armata Pharmaceuticals, Inc. file?
Public companies like Armata Pharmaceuticals, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.